EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY-NC-ND 4.0

[Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis

J P Velasco-Amador, Á Prados-Carmona, F J Navarro-Triviño

Actas Dermo-Sifiliográficas · 2024

DOI: 10.1016/j.ad.2024.01.016 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Actas Dermo-Sifiliográficas, 2024. Verfasst von J P Velasco-Amador und 2 weiteren Autor:innen. Beteiligte Einrichtung: Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain. Hauptthemen laut MEDLINE: Dermatitis, Allergic Contact, Diabetes Mellitus, Insulins. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 39 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The development and commercialization of glucose sensors and insulin pumps has revolutionized the management of diabetes. These devices have been linked to multiple cases of contact dermatitis in recent years, however, giving rise to a growing interest in identifying the sensitizing allergens. Isobornyl acrylate was clearly identified as one of the main allergens responsible for contact dermatitis among users of the FreeStyle glucose sensor and was subsequently removed from the product ingredients. Remarkably, however, it is still used in most other sensors on the market. The common adhesive ingredients colophony and abietic acid derivatives have also been shown to be sensitizing agents. New components under study, such as dipropylene glycol diacrylate, N,N-dimethylacrylamide, and triethylene glycol methacrylate have recently been identified as allergens, though they are not commercially available for clinical testing. The benefits offered by glucose sensors and insulin pumps may be offset by sensitization to product ingredients, in some cases forcing discontinuation and diminishing quality of life. Dermatologists should play a role in this clinical and research scenario, offering case-by-case guidance to endocrinologists on skin care and possible alternatives for patients with glucose sensors and insulin pumps who develop contact dermatitis. They should also collaborate with the manufacturers developing these devices.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Dermatitis, Allergic ContactDiabetes MellitusInsulinsHumansQuality of LifeBlood Glucose Self-MonitoringAcrylatesAllergensGlucosePatch Tests

Stichwörter der Autor:innen

AllergensAlérgenosBombas de insulinaDiabetes mellitusDispositivos médicosGlucose sensorInsulin pumpsMedical devicesPatch testsPruebas epicutáneasSensibilizaciónSensitizationSensor de glucosa

Substanzen

AcrylatesAllergensGlucoseInsulins

Autor:innen und Institutionen

  • Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain.
  • Unidad de Eczema de Contacto e Inmunoalergia, Servicio de Dermatología, Hospital Universitario San Cecilio, Granada, Spain. Electronic address: fntmed@gmail.com.

Zitieren

APA

Velasco-Amador, J. P., Prados-Carmona, Á., & Navarro-Triviño, F. J. (2024). [Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis. Actas Dermo-Sifiliográficas. https://doi.org/10.1016/j.ad.2024.01.016

Vancouver

Velasco-Amador JP, Prados-Carmona Á, Navarro-Triviño FJ. [Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis. Actas Dermo-Sifiliográficas. 2024. doi:10.1016/j.ad.2024.01.016

BibTeX
@article{VelascoAmador2024,
  author = {Velasco-Amador, J P and Prados-Carmona, Á and Navarro-Triviño, F J},
  title = {[Translated article] Medical Devices in Patients With Diabetes and Contact Dermatitis},
  journal = {Actas Dermo-Sifiliográficas},
  year = {2024},
  doi = {10.1016/j.ad.2024.01.016}
}
Kostenlos starten →